可分解的奈米载体对于药物安定性及控制释放的应用交通大学材料 .pdf

可分解的奈米载体对于药物安定性及控制释放的应用交通大学材料 .pdf

  1. 1、本文档共32页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
可分解的奈米载体对于药物安定性及控制释放的应用交通大学材料

奈 Stabilization and Controlled Release of Active Agents via a Degrading Nano-Carrier 料 : 年六 1 奈 奈 兩 奈料來奈 理行 料 數聯度 粒例數 量度度 量數 數 度 料良 量降 數 不不易 力奈來參 ABSTRACT The object of this study was to manipulate the drug permeability and stability of nano Ca-deficient hydroxyapatite/Chitosan (CDHA/CS) nanocomposite membrane incorporated with vitamins for drug storage and controlled release. The physical properties and drug permeation behaviors of Ca-deficient hydroxyapatite/Chitosan (CDHA/CS) nanocomposite membrane were systematically investigated in terms of different synthetic sequence and inorganic filler amount. It was found that the lowest permeation coefficient was obtained via in-situ process (P-CS-Ca), which was probably due to the higher crosslinking extent, better interface between filler and matrix, and smaller particle size, as well as dispersion. With an increase of CDHA content, both crosslinking and diffusion path would be increased so that the permeation coefficient of CDHA/CS composite membrane was reduced compared to that of pure chitosan membrane. A minimum permeation coefficient occurs at the CDHA content of 90%. In this condition, the drug can be safely stored for a long time. 2 料 了 例: 療… 料不連 料不奈料 不力 烈 C見 C 療 了便C 來療 了 療 奈 量 度 料 類 料 料料

您可能关注的文档

文档评论(0)

wujianz + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档